Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion type Assertion NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_head.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion description "[To understand the molecular basis of drug resistance observed in brain tumors, we examined the relationship between alteration of p16, a cyclin dependent kinase inhibitor whose functions are frequently lost in many human gliomas, and chemosensitivity of tumor cells to various kinds of anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_provenance.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion evidence source_evidence_literature NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_provenance.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion SIO_000772 10938390 NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_provenance.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion wasDerivedFrom befree-20150227 NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_provenance.
- NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_assertion wasGeneratedBy ECO_0000203 NP307926.RADi4U6WpoMolf7IOmHA19RhnnPAT17rVus8RmgmYRtgA130_provenance.